The goal is sustainable progress, improved health, and feeling better long term
Semaglutide acts on one receptor, GLP-1, while retatrutide acts on three: GLP-1, GIP, and glucagon
However, it is important to note that although the data so far is promising, the success of CT-388 in the T2D market will depend on continued positive results from ongoing and subsequent clinical trials (such as Phase 2 and 3 trials)
Your plan can flex up or down as you go, because maintenance is a medical strategy too
This is when appetite stabilizes, caloric intake naturally decreases, and stored fat begins breaking down efficiently